[Blood serum salicylate concentration and platelet aggregation after administration of acetylsalicylic acid]. 1980

A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
January 1986, Haemostasis,
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
August 1987, Thrombosis research,
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
January 1985, European journal of clinical pharmacology,
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
January 1976, L'Ateneo parmense. Acta bio-medica : organo della Societa di medicina e scienze naturali di Parma,
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
September 1969, Arzneimittel-Forschung,
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
January 1983, Biopharmaceutics & drug disposition,
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
January 1984, Folia haematologica (Leipzig, Germany : 1928),
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
November 1971, The Journal of pharmacology and experimental therapeutics,
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
January 1976, Haemostasis,
A Mazurowa, and T Olszańska-Skorek, and K Chojnowski, and I Pełczyńska, and J Skretkowicz, and E Szumejko, and A Eichelkraut
July 1985, La Clinica terapeutica,
Copied contents to your clipboard!